Serial Entrepreneur in Tech & Health Tech and soon Biotech | Building Therapies and New Biz Models for Rare Disease | Pro-Democracy | Imperfect but Proud 🇺🇸✡️
@bryan_johnson I run uncommon therapeutics a YC backed biotech working on Rett Syndrome and other rare diseases. My daughter has Rett and we’ve been using and building therapies for 5y with some success changing the disease trajectory. Think you can make waves, happy to help if I can
@elonmusk Trying to buy Tesla solar rn, and cant get a reply from project coordinator, cant get details answered. Site visit done 2.5w ago. Meanwhile other companies are answering my questions and just waiting for me to sign.
The world’s silence about the deliberate starvation of Israeli hostages—at the hands of Hamas and Islamic Jihad—is as deafening as its hypocrisy. Expect the images of emaciated Israeli bodies, starved in captivity, to appear nowhere in the pages of most major American newspapers.
A humanitarianism that devalues Jewish life is no humanitarianism at all, for it has been hollowed out by antisemitism.
“America would be better off if more people worked in manufacturing.”
• 80% of Americans agree
• 20% disagree
“I would be better off if I worked in a factory.”
• 25% of Americans agree
• 73% disagree
• 2% currently work in a factory
👉🏻 https://t.co/fq1rItVKC2
We're entering a new era of biotech, unlocked by an ever growing toolkit to treat disease. I'm excited to be building once again with @UncommonTx. More work ahead, but are driving hard to bring impactful medicines to patients with Rett.
🔬@UncommonTx is a disease-focused biotech that develops multiple high‐value ($b) therapeutics per disease by combining new tools and deep disease expertise to deliver cures.
https://t.co/Dojy4IeJWU
Congrats on the launch, @noahauerhahn and Ryan!
@NateSilver538 One violated the peaceful transfer of power, the other is protecting his son (from obviously frivolous litigation, but besides the point) because he has the power to do so (what a father should do). Neither norm violation is desirable, but they remain many std dev from each other
"it would cost taxpayers as much as $35 billion over the next decade"
So about 3.5 billion per year?
Obesity and overweight are estimated to have caused $425.5 billion in economic costs to U.S. businesses and employees in 2023 alone lmao
To spell this out as clearly as possible: getting obese and overweight people on GLP-1s will almost certainly result in a net decrease in taxes (all else equal) or just a more prosperous economy such that the average American is netted more money (all else equal).
The economic cost/benefit analysis is so comically weighted towards such a clear benefit it's nuts this hasn't already been done already.
@academic_la Hard to support the tribe, but also call it on its bullshit from time to time. No one will agree with you each time you do that, cause we all have slightly different views on each circumstance. Good for you for trying!